BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33942544)

  • 1. Donor Treg expansion by liposomal α-galactosylceramide modulates Tfh cells and prevents sclerodermatous chronic graft-versus-host disease.
    Sugiura H; Matsuoka KI; Fukumi T; Sumii Y; Kondo T; Ikegawa S; Meguri Y; Iwamoto M; Sando Y; Nakamura M; Toji T; Ishii Y; Maeda Y
    Immun Inflamm Dis; 2021 Sep; 9(3):721-733. PubMed ID: 33942544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Bcl-6 prevents sclerodermatous chronic graft-versus-host disease by abrogating T follicular helper differentiation in mice.
    Chen X; Wang Y; Huang X; Geng S; Li C; Zeng L; Huang L; Du X; Weng J; Lai P
    Int Immunopharmacol; 2023 Apr; 117():109746. PubMed ID: 36827923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invariant natural killer T cells ameliorate murine chronic GVHD by expanding donor regulatory T cells.
    Du J; Paz K; Thangavelu G; Schneidawind D; Baker J; Flynn R; Duramad O; Feser C; Panoskaltsis-Mortari A; Negrin RS; Blazar BR
    Blood; 2017 Jun; 129(23):3121-3125. PubMed ID: 28416503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Foxp3
    Chen YB; Efebera YA; Johnston L; Ball ED; Avigan D; Lekakis LJ; Bachier CR; Martin P; Duramad O; Ishii Y; Han S; Jung YJ; Lee D; Kunkel L; Negrin RS; Bui JD
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):625-634. PubMed ID: 28104514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordination between T helper cells, iNKT cells, and their follicular helper subsets in the humoral immune response against Clostridium difficile toxin B.
    Rampuria P; Lang GA; Devera TS; Gilmore C; Ballard JD; Lang ML
    J Leukoc Biol; 2017 Feb; 101(2):567-576. PubMed ID: 27566831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant germinal center formation, follicular T-helper cells, and germinal center B-cells were involved in chronic graft-versus-host disease.
    Shao L; Lie AK; Zhang Y; Wong CH; Kwong YL
    Ann Hematol; 2015 Sep; 94(9):1493-504. PubMed ID: 25963280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of Foxp3+ T cell subsets involved in incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Hu Y; Cui Q; Ye Y; Luo Y; Tan Y; Shi J; Huang H
    Hematol Oncol; 2017 Mar; 35(1):118-124. PubMed ID: 26439896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating T follicular helper cells with increased function during chronic graft-versus-host disease.
    Forcade E; Kim HT; Cutler C; Wang K; Alho AC; Nikiforow S; Ho VT; Koreth J; Armand P; Alyea EP; Blazar BR; Soiffer RJ; Antin JH; Ritz J
    Blood; 2016 May; 127(20):2489-97. PubMed ID: 26944544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation.
    Wolf D; Barreras H; Bader CS; Copsel S; Lightbourn CO; Pfeiffer BJ; Altman NH; Podack ER; Komanduri KV; Levy RB
    Biol Blood Marrow Transplant; 2017 May; 23(5):757-766. PubMed ID: 28219835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease.
    Whangbo JS; Nikiforow S; Kim HT; Wahl J; Reynolds CG; Rai SC; Kim S; Burden A; Alho AC; Lacerda JF; Alyea EP; Cutler CS; Ho VT; Antin JH; Soiffer RJ; Ritz J; Koreth J
    Blood Adv; 2022 Nov; 6(21):5786-5796. PubMed ID: 35475885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion of circulating extrafollicular helper T-like cells in patients with chronic graft-versus-host disease.
    Jin H; Yang K; Zhang H; Chen Y; Qi H; Fan Z; Huang F; Xuan L; Lin R; Zhao K; Liu Q
    J Autoimmun; 2019 Jun; 100():95-104. PubMed ID: 30878167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CD4+CD25+highFoxp3+CD62L+ regulatory T cells and invariant NKT cells in human allogeneic hematopoietic stem cell transplantation.
    Vela-Ojeda J; Montiel-Cervantes L; Granados-Lara P; Reyes-Maldonado E; García-Latorre E; Garcia-Chavez J; Majluf-Cruz A; Mayani H; Borbolla-Escoboza JR; Esparza MG
    Stem Cells Dev; 2010 Mar; 19(3):333-40. PubMed ID: 19919293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible T-Cell Co-Stimulator Impacts Chronic Graft-Versus-Host Disease by Regulating Both Pathogenic and Regulatory T Cells.
    Zhang M; Wu Y; Bastian D; Iamsawat S; Chang J; Daenthanasanmak A; Nguyen HD; Schutt S; Dai M; Chen F; Suh WK; Yu XZ
    Front Immunol; 2018; 9():1461. PubMed ID: 29988391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of Donor-Origin Mouse Embryonic Stem Cell-Derived Thymic Epithelial Progenitors Prevents the Development of Chronic Graft-versus-Host Disease in Mice.
    Hu R; Liu Y; Su M; Song Y; Rood D; Lai L
    Stem Cells Transl Med; 2017 Jan; 6(1):121-130. PubMed ID: 28170174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Role and Mechanism of Tfh and B Cell in Human Chronic Graft-Versus-Host-Disease].
    Lyu KK; Xu MM; DU YY; He XF; Chen F; Ma X; Han Y; Wu DP; Liu YJ; Xu MZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):593-599. PubMed ID: 35396002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease.
    Soares MV; Azevedo RI; Ferreira IA; Bucar S; Ribeiro AC; Vieira A; Pereira PNG; Ribeiro RM; Ligeiro D; Alho AC; Soares AS; Camacho N; Martins C; Lourenço F; Moreno R; Ritz J; Lacerda JF
    Front Immunol; 2019; 10():334. PubMed ID: 30894856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Galactosylceramide treatment before allergen sensitization promotes iNKT cell-mediated induction of Treg cells, preventing Th2 cell responses in murine asthma.
    Chen Q; Guo X; Deng N; Liu L; Chen S; Wang A; Li R; Huang Y; Ding X; Yu H; Hu S; Nie H
    J Biol Chem; 2019 Apr; 294(14):5438-5455. PubMed ID: 30745361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic expansion of donor-derived, naturally occurring CD4(+)Foxp3(+) regulatory T cells reduces acute graft-versus-host disease lethality without abrogating the graft-versus-leukemia effect in murine models.
    Duramad O; Laysang A; Li J; Ishii Y; Namikawa R
    Biol Blood Marrow Transplant; 2011 Aug; 17(8):1154-68. PubMed ID: 21145405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicles derived from mesenchymal stem cells prevent skin fibrosis in the cGVHD mouse model by suppressing the activation of macrophages and B cells immune response.
    Guo L; Lai P; Wang Y; Huang T; Chen X; Geng S; Huang X; Luo C; Wu S; Ling W; Huang L; Du X; Weng J
    Int Immunopharmacol; 2020 Jul; 84():106541. PubMed ID: 32402950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of T Follicular Helper Cells in the Peripheral Blood of Patients with Chronic Graft-versus-Host Disease.
    Knorr DA; Wang H; Aurora M; MacMillan ML; Holtan SG; Bergerson R; Cao Q; Weisdorf DJ; Cooley S; Brunstein C; Miller JS; Wagner JE; Blazar BR; Verneris MR
    Biol Blood Marrow Transplant; 2016 May; 22(5):825-33. PubMed ID: 26806586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.